Under construction – not a live service
Sign in

2023-506550-20-00CompletedPhase 2/3

FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITOR-PILOT)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Jun 2025

Next steps

Brief summary (registry, in English)

The primary objective of the MONITOR-RCT is to demonstrate that in patients with metastatic breast cancer, response monitoring based on FDG-PET/CT is superior to response monitoring based on CT with respect to overall survival. The objective will be based on applying standardized response evaluation criteria, using an appropriate adaptation of the PERCIST criteria for FDG-PET/CT and the RECIST1.1 criteria for CT.

Status (registry)
Completed
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
30 (actual)
First submitted
8 Dec 2023
Start date
5 Jul 2024
Lead sponsor
Odense University Hospital
EU CT number
2023-506550-20-00

What you commit to

  • Study type: Interventional · Phase 2/3
  • Participants enrolled: 30
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Ongoing oncological treatment for another cancer
  • Allergy to FDG

Other

  • Pregnant or lactating women
  • Exclusively brain metastasis

Who the study is looking for

  • Women and men aged≥18 years
  • Diagnosis of distant relapsed MBC (biopsy-verified) or de novo breast cancer (biopsy verification of primary tumor and disseminated disease at baseline scan)
  • Considered eligible for first-line systemic treatment
  • Considered eligible for continuous treatment monitoring by scans
  • Signed informed consent
  • Ability to read and understand Danish language

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (3)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Esbjerg SygehusEsbjergDenmarkCompleted
Odense University HospitalOdense CDenmarkCompleted
Lillebaelt HospitalVejleDenmarkCompleted

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.